Faes Farma, S.A. (BME:FAE)

Market Cap	1.16B
Revenue (ttm)	504.04M
Net Income (ttm)	97.59M
Shares Out	311.25M
EPS (ttm)	0.31
PE Ratio	11.88
Forward PE	12.35
Dividend	0.16 (4.25%)
Ex-Dividend Date	Jan 9, 2025

Volume	304,313
Average Volume	581,717
Open	3.640
Previous Close	3.690
Day's Range	3.685 - 3.730
52-Week Range	2.910 - 3.830
Beta	0.51
RSI	72.03
Earnings Date	Feb 25, 2025

About Faes Farma

Faes Farma, S.A., researches, develops, produces, and markets pharmaceutical products, healthcare products, and raw materials worldwide. It operates through Pharmaceutical and Healthcare Specialties; Animal Nutrition and Health; and Pharmaceutical Raw Materials segments. It offers products for various therapeutic areas. The company also provides animal nutrition and health products. Faes Farma, S.A. was incorporated in 1933 and is headquartered in Leioa, Spain.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1933
• Employees: 1,748
• Stock Exchange: Madrid Stock Exchange
• Ticker Symbol: FAE

Financial Performance

In 2023, Faes Farma's revenue was 473.09 million, an increase of 2.46% compared to the previous year's 461.72 million. Earnings were 91.90 million, an increase of 2.69%.